NHI-2
NHI-2 is a selective LDHA inhibitor (IC50 = 14.7 μM) that disrupts cancer cell metabolism, exhibiting potent antiproliferative effects in vitro and suppressing tumor growth in murine melanoma models, making it a valuable tool for oncology and cancer metabolism research.
Product Specifications
CAS Number
1269802-97-2
Product Name Alternative
NHI 2, NHI2
Field of Research
Cell Biology
Purity
>98%
Bioactivity
LDHA inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml) .
Smiles
C (F) (F) (F) C1=C2C (N (O) C (C (OC) =O) =C2) =CC (=C1) C3=CC=CC=C3
Molecular Formula
C17H12F3NO3
Molecular Weight
335.28
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
Methyl 1-Hydroxy-6-phenyl-4-trifluoromethyl-1H-indole-2-carboxylate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038008-APC 200 µL
LUC7L, ID (LUC7L, LUC7L1, Putative RNA-binding protein Luc7-like 1, Putative SR protein LUC7B1, SR+89) (APC) discontinued
Sign In for Pricing
View Details 
K4360306 1.0 µg DNA
Chrm1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
GTR15230798 1 Vial
Lentiviral mouse Rars2 shRNA (UAS) - Lentiviral mouse Rars2 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details